Literature DB >> 18334272

Implications of the DSM's emphasis on sadness and anhedonia in major depressive disorder.

Julia D Buckner1, Thomas E Joiner, Jeremy W Pettit, Peter M Lewinsohn, Norman B Schmidt.   

Abstract

At least five symptoms must occur for a DSM diagnosis of major depressive disorder (MDD), one of which must be sadness or anhedonia. The present study is the first known investigation of the implications of the presence or absence of these prioritized symptoms on symptom expression and clinical characteristics among 564 young adults with MDD. Differences in symptom expression and clinical characteristics occurred among MDD participants with sadness relative to those without sadness as well as among MDD participants with anhedonia relative to those without anhedonia. Differential symptom expression could have important implications for the etiology, prevention, and treatment of MDD.

Entities:  

Mesh:

Year:  2008        PMID: 18334272      PMCID: PMC3688280          DOI: 10.1016/j.psychres.2007.05.010

Source DB:  PubMed          Journal:  Psychiatry Res        ISSN: 0165-1781            Impact factor:   3.222


  10 in total

1.  Psychomotor retardation and anhedonia in depression.

Authors:  M R Lemke; P Puhl; N Koethe; T Winkler
Journal:  Acta Psychiatr Scand       Date:  1999-04       Impact factor: 6.392

2.  Emotional eating in overweight, normal weight, and underweight individuals.

Authors:  Allan Geliebter; Angela Aversa
Journal:  Eat Behav       Date:  2003-01

3.  The diagnostic validity of melancholic major depression in a population-based sample of female twins.

Authors:  K S Kendler
Journal:  Arch Gen Psychiatry       Date:  1997-04

4.  Retrospective assessment of prepubertal major depression with the Kiddie-SADS-e.

Authors:  H Orvaschel; J Puig-Antich; W Chambers; M A Tabrizi; R Johnson
Journal:  J Am Acad Child Psychiatry       Date:  1982-07

5.  Evaluation of cognitive diathesis-stress models in predicting major depressive disorder in adolescents.

Authors:  P M Lewinsohn; T E Joiner ; P Rohde
Journal:  J Abnorm Psychol       Date:  2001-05

6.  Life events and prodromal symptoms in bulimia nervosa.

Authors:  A R Raffi; M Rondini; S Grandi; G A Fava
Journal:  Psychol Med       Date:  2000-05       Impact factor: 7.723

7.  The assessment of affective disorders in children and adolescents by semistructured interview. Test-retest reliability of the schedule for affective disorders and schizophrenia for school-age children, present episode version.

Authors:  W J Chambers; J Puig-Antich; M Hirsch; P Paez; P J Ambrosini; M A Tabrizi; M Davies
Journal:  Arch Gen Psychiatry       Date:  1985-07

8.  Adolescent psychopathology: I. Prevalence and incidence of depression and other DSM-III-R disorders in high school students.

Authors:  P M Lewinsohn; H Hops; R E Roberts; J R Seeley; J A Andrews
Journal:  J Abnorm Psychol       Date:  1993-02

9.  The loss of appetite during depression with melancholia: a qualitative and quantitative analysis.

Authors:  M Kazes; J M Danion; D Grangé; A Pradignac; J L Schlienger
Journal:  Int Clin Psychopharmacol       Date:  1993       Impact factor: 1.659

10.  Differences between anhedonic and normally hedonic depressive states.

Authors:  J Fawcett; D C Clark; W A Scheftner; D Hedeker
Journal:  Am J Psychiatry       Date:  1983-08       Impact factor: 18.112

  10 in total
  18 in total

1.  Excitability and irritability in preschoolers predicts later psychopathology: The importance of positive and negative emotion dysregulation.

Authors:  Alecia C Vogel; Joshua J Jackson; Deanna M Barch; Rebecca Tillman; Joan L Luby
Journal:  Dev Psychopathol       Date:  2019-05-21

Review 2.  Reward Network Modulation as a Mechanism of Change in Behavioral Activation.

Authors:  Gabriela A Nagy; Paul Cernasov; Angela Pisoni; Erin Walsh; Gabriel S Dichter; Moria J Smoski
Journal:  Behav Modif       Date:  2018-10-13

3.  Effects of Dimensional and Categorical Classification on the Clinical Manifestation of Major Depressive Disorder.

Authors:  Hüseyin Güleç; Aytül Karabekİroğlu; Aynil Yenel; Mustafa Burak Baykaran; Elif Keleş Ünal
Journal:  Noro Psikiyatr Ars       Date:  2014-09-01       Impact factor: 1.339

4.  Prevalence, correlates, and symptom profiles of depression among men with a history of military service.

Authors:  Peter C Britton; Robert M Bossarte; Naiji Lu; Hua He; Glenn W Currier; John Crilly; Tom Richardson; Xin Tu; Kerry L Knox
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2010-07-23       Impact factor: 4.328

5.  Pharmacological Treatments for Anhedonia.

Authors:  Matthew E Klein; Ariela Buxbaum Grice; Sahil Sheth; Megan Go; James W Murrough
Journal:  Curr Top Behav Neurosci       Date:  2022

Review 6.  Introducing a depression-like syndrome for translational neuropsychiatry: a plea for taxonomical validity and improved comparability between humans and mice.

Authors:  Mathias V Schmidt; Jan M Deussing; Iven-Alex von Mücke-Heim; Lidia Urbina-Treviño; Joeri Bordes; Clemens Ries
Journal:  Mol Psychiatry       Date:  2022-09-14       Impact factor: 13.437

7.  Gender differences in the impact of daily sadness on 24-h heart rate variability.

Authors:  Bart Verkuil; Jos F Brosschot; Andrea H Marques; Kevin Kampschroer; Esther M Sternberg; Julian F Thayer
Journal:  Psychophysiology       Date:  2015-09-04       Impact factor: 4.016

8.  Serotonin transporter clustering in blood lymphocytes predicts the outcome on anhedonia scores in naïve depressive patients treated with antidepressant medication.

Authors:  Jose Manuel Olivares; Hector J Caruncho; Tania Rivera-Baltanas; Roberto Carlos Agis-Balboa; Raquel Romay-Tallon; Lisa E Kalynchuk
Journal:  Ann Gen Psychiatry       Date:  2015-12-21       Impact factor: 3.455

Review 9.  Sadness as an integral part of depression.

Authors:  Sabine Mouchet-Mages; Franck J Baylé
Journal:  Dialogues Clin Neurosci       Date:  2008       Impact factor: 5.986

Review 10.  Targeting metabotropic glutamate receptors for the treatment of depression and other stress-related disorders.

Authors:  Shalini Dogra; P Jeffrey Conn
Journal:  Neuropharmacology       Date:  2021-06-25       Impact factor: 5.273

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.